CID 016
Alternative Names: CID-016Latest Information Update: 13 Feb 2024
At a glance
- Originator Circle Pharma
- Class Antineoplastics; Macrocyclic compounds
- Mechanism of Action Cyclin A inhibitors; Cyclin B inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Breast cancer